Nature Reviews Clinical Oncology

Vol. 23, Issue 4 Issue 4 2026
10
Articles

Articles in this Issue

CDK4/6 inhibition provides additional efficacy in HER2+, HR+ breast cancer

David Killock Apr 01, 2026 pp. 232-232 10.1038/s41571-026-01133-2

Cancer statistics, 2026: divergent trends and the implementation gap

Liqun Zhang, Jingdong Zhang Apr 01, 2026 pp. 237-238 10.1038/s41571-026-01132-3

First-line therapy for CLL: options abound

Jennifer R. Brown Apr 01, 2026 pp. 235-236 10.1038/s41571-026-01127-0

Sacituzumab govitecan plus pembrolizumab improves outcomes

Peter Sidaway Apr 01, 2026 pp. 231-231 10.1038/s41571-026-01129-y

Beyond the R² horizon: new triplet regimens for relapsed and/or refractory follicular lymphoma

Loretta J. Nastoupil Apr 01, 2026 pp. 233-234 10.1038/s41571-026-01125-2

Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer

Soraia Lobo-Martins, Stephen J. Luen, Martine Piccart et al. Apr 01, 2026 pp. 297-315 10.1038/s41571-026-01120-7

Anbenitamab is a new second-line option in G/GEJ adenocarcinoma

Diana Romero Apr 01, 2026 pp. 231-231 10.1038/s41571-026-01124-3

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer

Liora Schultz, Kevin McNerney, Adam J. Lamble et al. Apr 01, 2026 pp. 260-278 10.1038/s41571-025-01115-w

Diagnosis, risk stratification and management of smouldering multiple myeloma

Saurabh Zanwar, Shaji Kumar, S. Vincent Rajkumar Apr 01, 2026 pp. 279-296 10.1038/s41571-026-01119-0

MicroRNAs in oncology: a translational perspective in the era of AI

Ancuta Jurj, Mihnea P. Dragomir, Ziyi Li et al. Apr 01, 2026 pp. 239-259 10.1038/s41571-025-01114-x

All Issues

Issue 7 - Issue 7 11 Issue 6 - Issue 6 10 Issue 5 - Issue 5 10 Issue 4 - Issue 4 10 Issue 3 - Issue 3 10 Issue 2 - Issue 2 9 Issue 1 - Issue 1 12
Issue 9 - Issue 9 11 Issue 8 - Issue 8 14 Issue 7 - Issue 7 10 Issue 6 - Issue 6 9 Issue 5 - Issue 5 11 Issue 4 - Issue 4 10 Issue 3 - Issue 3 12 Issue 2 - Issue 2 8 Issue 12 - Issue 12 13 Issue 11 - Issue 11 9 Issue 10 - Issue 10 8 Issue 1 - Issue 1 12

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page